Pembrolizumab plus axitinib for metastatic papillary and chromophobe kidney cancer
Non-clear cell kidney cancer is a group of different subtypes [...]
Non-clear cell kidney cancer is a group of different subtypes [...]
A recent paper published in The Oncologist has shown that [...]
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
When ipilimumab plus nivolumab or axitinib plus pembrolizumab are used [...]
A biomarker is a biological molecule found in blood, other body [...]
Neoadjuvant treatment is medication that is given before surgery to [...]
Just over half of the patients from a phase 2 [...]
Results from the NeoAvAx clinical trial were presented at the [...]
The KEYNOTE-426 study of the immune checkpoint inhibitor, pembrolizumab plus [...]
This Practice Update interview with Dr Monty Pal from City [...]